The European Commission reached a provisional agreement with BioNTech SE and Pfizer Inc. for the supply of 200 million doses of a successful Covid-19 vaccine. AstraZeneca Plc, meantime, paused its late-stage vaccine study after a participant became ill.
Germany’s virus reproduction number held above a key threshold, more evidence of a resurgence in Europe, while the death toll in India continued to mount. The country surpassed Brazil in recent days to become second in Covid-19 cases globally.
The European Commission reached a provisional agreement with BioNTech SE and Pfizer Inc. for the supply of 200 million doses of a successful Covid-19 vaccine. AstraZeneca Plc, meantime, paused its late-stage vaccine study after a participant became ill.
Germany’s virus reproduction number held above a key threshold, more evidence of a resurgence in Europe, while the death toll in India continued to mount. The country surpassed Brazil in recent days to become second in Covid-19 cases globally.